Apo A5 -1131T/C, FgB -455G/A, -148C/T, and CETP TaqIB gene polymorphisms and coronary artery disease in the Chinese population: A meta-analysis of 15,055 subjects

Molecular Biology Reports

Volumn 40, Issue 2, 2013, Pages 1997-2014

  Li, Yan Yan ^a   Wu, Xiao Yan ^a   Xu, Jian ^a   Qian, Yun ^a   Zhou, Chuan Wei ^a   Wang, Bei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

1131T C; 148C T; 455G A; Apolipoprotein A5; B1 B2; Chinese; Cholesteryl ester transfer protein; Coronary artery disease; Fibrinogen ; Polymorphism; TaqIB

Indexed keywords

APOLIPOPROTEIN A5; CHOLESTEROL ESTER TRANSFER PROTEIN; FIBRINOGEN;

APO A5 GENE; ARTICLE; CETP GENE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; ETHNICITY; FGB GENE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MODEL; GENETIC POLYMORPHISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; SYSTEMATIC REVIEW;

APOLIPOPROTEINS A; CASE-CONTROL STUDIES; CHINA; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY ARTERY DISEASE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84878366077     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2257-9     Document Type: Article

References (72)

1. Zemel PC, Sowers JR (1990) Relation between lipids and atherosclerosis: epidemiologic evidence and clinical implications. Am J Cardiol 66:7I-12I
2. Pennacchio LA, Olivier M, Hubacek JA et al (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169-173
3. van der Vliet HN, Sammels MG, Leegwater AC et al (2001) Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 276:44512-44520
4. Smith CE, Tucker KL, Lai CQ et al (2010) Apolipoprotein A5 and lipoprotein lipase interact to modulate anthropometric measures in Hispanics of Caribbean origin. Obesity (Silver Spring) 18:327-332
5. Tousoulis D, Papageorgiou N, Androulakis E et al (2011) Fibrinogen and cardiovascular disease: genetics and biomarkers. Blood 25:239-245
6. Thomas A, Lamlum H, Humphries S, Green F (1994) Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (HaeIII), C/T-148 (HindIII/AluI), T/G + 1689 (AvaII), and BclI (beta-fibrinogen) and TaqI (alpha-fibrinogen), and their detection by PCR. Hum Mutat 3:79-81
7. Genest JJ Jr, Martin-Munley SS, McNamara JR et al (1992) Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85:2025-2033
8. Alssema M, El-Harchaoui K, Schindhelm RK et al (2010) Fasting cholesteryl ester transfer protein concentration is independently associated with the postprandial decrease in high-density lipoprotein cholesterol concentration after fat-rich meals: the Hoorn prandial study. Metabolism 59:854-860
9. Chen SN, Cilingiroglu M, Todd J et al (2009) Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis. BMC Med Genet 10:111
10. Szalai C, Keszei M, Duba J et al (2004) Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 173:109-114
11. Pennacchio LA, Olivier M, Hubacek JA et al (2002) Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11:3031-3038
12. Endo K, Yanagi H, Araki J et al (2002) Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet 111:570-572
13. Henry I, Uzan G, Weil D et al (1984) The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2. Am J Hum Genet 36:760-768
14. Humphries SE, Cook M, Dubowitz M et al (1987) Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1:1452-1455
15. Ordovas JM (2000) Genetic polymorphisms and activity of cholesterol ester transfer protein (CETP): should we be measuring them? Clin Chem Lab Med 38:945-949
16. Yilmaz H, Isbir T, Agachan B et al (2005) Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients. Cell Biochem Funct 23:23-28
17. Bi N, Yan SK, Li GP et al (2005) Polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene in patients with coronary artery disease. Chin J Cardiol 33:116-121
18. Liu H, Zhang S, Lin JL et al (2005) Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism 54:568-572
19. Chen Y, Xu LP, Zhang JQ et al (2011) Study on the relationship between apolipoprotein A5 gene polymorphism and coronary artery disease. Chin J Conval Med 20:487-489
20. Smith GD, Harbord R, Milton J et al (2005) Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies. Arterioscler Thromb Vasc Biol 25:2228-2233
21. Sun C, Liang L, Li WJ et al (2007) Nucleotide polymorphisms and haplotypes in α- and β-fibrinogen genes and their relationship to coronary heart disease. Chin J Arteriosclerosis 15:699-702
22. Zhang YX, Han L, Ma X (2000) Study of correlation of human β-fibrinogen G/A -455 polymorphism and the thrombotic complicationsof atherosclerosis. J Xi'an Med Univ 21:115-118
23. Ma HL, Ge JB, Wang Y et al (2005) Association of fibrinogen and its gene β148 and β854 polymorphisms with coronary heart disease. Chin J Arteriosclerosis 13:351-354
24. Rahimi Z, Nourozi-Rad R, Vaisi-Raygani A et al (2011) Association between cholesteryl ester transfer protein TaqIB variants and risk of coronary artery disease and diabetes mellitus in the population of Western Iran. Genet Test Mol Biomarkers [Epub ahead of print]
25. Tanrikulu-Kucuk S, Ademoglu E, Gurdol F et al (2010) Cholesteryl ester transfer protein Taq1B polymorphism in an angiographically assessed Turkish population: no effects on coronary artery disease risk. Genet Test Mol Biomarkers 14:637-642
26. Zhang GB, Jiang ZW, Sun BG et al (2005) Relationship of TaqIB polymorphism in the cholesteryl ester transfer protein gene to coronary artery disease. Chin J Arterioscler 13:88-90
27. Zhao SP, Li H, Xiao ZJ, Nie S (2004) The effect of TaqIB polymorphism of cholesteryl ester transfer protein gene on the lipoprotein level. Zhonghua Xin Xue Guan Bing Za Zhi 32:816-818
28. Cochran WG (1968) The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 24:295-313
29. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
30. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
31. Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629-634
32. Tang YB, Sun P, Guo DP et al (2005) Association between apolipoprotein A5-1131T > C polymorphism and susceptibility of coronary artery disease in Chinese. Chin J Med Genet 22:281-283
33. Yin SX (2006) A study on the genes single nucleotide polymorphism of apolipoprotein A5 and C3 in patients with coronary artery disease. Qingdao University Press, Qingdao
34. Qiu F (2007) The association of polymorphisms in apolipoproteina 5 gene with blood lipids and heart cerebrovascular disease. Southeast University Press, Nanjing
35. Yang F, Ng ZJ, Wang LS (2007) Association of APOA5 gene -1131T > C single nucleotide polymorphism with coronary heart disease among Chinese Han population. Shandong Med J 47:1-3
36. Yu Y, Xue L, Zhao CY et al (2007) Study on polymorphism in the apolipoprotein A5 gene in patients with premature coronary heart disease. J Peking Univ (Health Sciences) 39:576-580
37. Zhang YQ (2007) Associations of apoA 5 polymorphisms, blood lipids and coronary heart disease in the Chinese. Zhejiang University Press, Hangzhou
38. Xu L, He T (2008) Correlation of apolipoprotein A5 SNP3 gene single nucleotide polymorphism with coronary artery disease in Chinese. Shandong Med J 48:1-3
39. Zhao L (2008) Association between apolipoprotein A5-1131 T > C polymorphism and coronary heart disease in xinjiang Uygur. Xinjiang Medical University Press, Wulumuqi
40. Li FQ, Liu GX, Yang ZG et al (2001) β-fibrinogen -455 gene polymorphism associated with plasma fibrinogen levels in ischemic heart disease. Chin J Gerontol 21:417-419
41. Gong WX, Cai YM, Peng J et al (2002) Study on the promoter region of β fibrinogen gene polymorphism in patients with coronary heart disease. Chin J Arteriosclerosis 10:140-143
42. Jin W, Liu Y, Jiang ZW et al (2002) Relationship between single nucleotide polymorphisms in the 5′-promoter region of beta fibrinogen gene and coronary artery disease: a case-control study in Chinese population. J Diagn Concep Pract 1:224-228
43. Liu R, Li JZ, Mu H et al (2002) The relationship of beta-fibrinogen gene polymorphisms and ischemic cardiocerebral vascular disease. Chin J Hematol 23:453-456
44. Lu CZ, Tian HM, Li YG (2003) Plasma fibrinogen gene β-455G/A polymorphism and plasma fibrinogen level in patients with acute coronary syndromes. Mol Cardiol Chin 3:323-325
45. Sun H, Zhang W, Lu FH et al (2004) Association of fibrinogen β-455G/A gene polymorphism with hypertension and coronary heart disease. Chin J Arteriosclerosis 12:199-202
46. Wang AL, Yu YX, Xu Y et al (2005) Research of association between β fibrinogen gene 455G/A polymorphisms and acute myocardial infarction. Acta Universitatis Medicinalis Anhui 40:238-240
47. Wang ZX, Yang XJ, Pan M et al (2007) Association of two polymorphism in the fibrinogen β gene 5′ promoter region with plasma levels and coronary artery disease susceptibility in Chinese population. Jiangsu Med J 33:757-759
48. Li Z, Bao J (2008) Association of fibrinogen β-455G/A gene polymorphism with coronary heart disease. Chin J Gerontol 28:2472-2473
49. Sun A, Ma H, Xu D et al (2009) Association between -455G/A and fibrinogen in a Chinese population. Acta Cardiol 64:357-361
50. Zhang XH, Xu G, Zhao XY et al (2003) Study of fibrinogen β-148C/T gene polymorphism in patients with coronary heart disease and stroke. Chin J Emerg Med 12:683-684
51. Kou L, Qin Q, Cui RZ et al (2004) A study on β-fibrinogen-148C/T polymorphism and platelet membrane glycoprotein VIT13254C polymorphism of coronary heart disease. Mol Cardiol China 4:328-334
52. Zhou S, Zhao LS, Wang HK et al (2009) Relationship between gene polymorphism of fibrinogen 148C/T and coronary heart disease. Shandong Med J 49:10-12
53. Wang W, Zhou X, Liu F et al (2004) Association of the TaqIB polymorphism and D442G mutation of cholesteryl ester transfer protein gene with coronary heart disease. Zhonghua Xin Xue Guan Bing Za Zhi 32:981-985
54. Yan SK, Zhu YL, Cheng S et al (2004) Relationship between coronary heart disease and TaqIB, MspI polymorphisms of cholesteryl ester transfer protein gene in Han nationality. Chin J Lab Med 27:671-675
55. Hsieh MC, Tien KJ, Chang SJ et al (2007) Cholesteryl ester transfer protein B1B1 genotype as a predictor of coronary artery disease in Taiwanese with type 2 diabetes mellitus. Metabolism 56:745-750
56. Wang SH, Cui HB, Wang DQ et al (2008) Geographical characteristics of single nucleotide polymorphism of candidate genes associated with coronary artery disease in Chinese Han population. Zhonghua Xin Xue Guan Bing Za Zhi 36:24-29
57. Zhou DF, Yun ML, Zhang Y et al (2010) Dertermination of cholesteryl ester transport protein gene polymorphism in patients with coronal heart disease from Hainan Li nationality. Shandong Med J 50:26-28
58. Zhang Z, Peng B, Gong RR et al (2011) Apolipoprotein A5 polymorphisms and risk of coronary artery disease: a meta-analysis. Biosci Trends 5:165-172
59. Hubacek JA, Skodová Z, Adámková V et al (2004) The influence of APOAV polymorphisms (T-1131 > C and S19 > W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet 65:126-130
60. Hsu LA, Ko YL, Chang CJ et al (2006) Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 185:143-149
61. Yan SK, Cheng XQ, Song YH et al (2005) Apolipoprotein A5 gene polymorphism -1131T->C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese. Clin Chem Lab Med 43:607-612
62. Zhai G, Li M, Zhu C (2011) APOA5 -1131T/C polymorphism is associated with coronary artery disease in a Chinese population: a meta-analysis. Clin Chem Lab Med 49:535-539
63. Brown ET, Fuller GM (1998) Detection of a complex that associates with the Bbeta fibrinogen G-455-A polymorphism. Blood 92:3286-3293
64. Danesh J, Collins R, Peto R (1997) Chronic infections and coronary heart disease: is there a link? Lancet 350:430-436
65. Meade TW (1987) Hypercoagulability and ischaemic heart disease. Blood Rev 1:2-8
66. Luc G, Bard JM, Juhan-Vague I et al (2003) C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME study. Arterioscler Thromb Vasc Biol 23:1255-1261
67. Krauss RM (2001) Dietary and genetic effects on LDL heterogeneity. World Rev Nutr Diet 89:12-22
68. Ordovas JM, Cupples LA, Corella D et al (2000) Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 20:1323-1329
69. Corella D, Carrasco P, Amiano P et al (2010) Common cholesteryl ester transfer protein gene variation related to high-density lipoprotein cholesterol is not associated with decreased coronary heart disease risk after a 10-year follow-up in a Mediterranean cohort: Modulation by alcohol consumption. Atherosclerosis 211:531-538
70. Kaestner S, Patsouras N, Spathas DH et al (2010) Lack of association between the cholesteryl ester transfer protein gene-TaqIB polymorphism and coronary restenosis following percutaneous transluminal coronary angioplasty and stenting: a pilot study. Angiology 61:338-343
71. Boekholdt SM, Sacks FM, Jukema JW et al (2005) Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 111:278-287
72. Hassanzadeh T, Firoozrai M, Zonouz AE et al (2009) Taq1B polymorphism of cholesteryl ester transfer protein (CETP) gene in primary combined hyperlipidaemia. Indian J Med Res 129:293-298